MDOMF yields 1.69% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 8
Combined, MDOMF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MDOMF + PFE for your $10,000?
Mandom Corporation engages in the manufacture and sale of cosmetics, perfumes, and quasi-drugs in Japan, Indonesia, and internationally. The company offers a range of products, including men's everyday grooming products, as well as general fashion items, such as hair styling, skin care, and body care products; and hair coloring, scalp care, and face care products under the Gatsby and Lúcido brands. It also provides a range of women's grooming and fashion items, such as hair styling and body care products comprises make-up and skin care items, as well as hair styling, coloring, and treatment products under the Bifesta, Pixy, Lúcido-L, and Pucelle brands. In addition, the company offers professional-use products and technologies to hair salons through distributors; and insurance agency, travel, and general services. It sells its products to drug stores and convenience stores through distributors. The company was formerly known as Tancho Corporation and changed its name to Mandom Corporation in April 1971. Mandom Corporation was incorporated in 1927 and is headquartered in Osaka, Japan.
Full MDOMF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.